[1] Blackburn E H. Structure and function of telomeres[J]. Nature, 1991, 350(6319): 569-573.
[2] Chin L, Artandi S E, Shen Q, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis[J]. Cell, 1999, 97(4): 527-538.
[3] Allsopp R C, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts[J]. Proc Natl Acad Sci U S A, 1992, 89(21): 10114-10118.
[4] Blackburn E H, Greider C W, Szostak J W. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging[J]. Nat Med, 2006, 12(10): 1133-1138.
[5] Masutomi K, Yu E Y, Khurts S, et al. Telomerase maintains telomere structure in normal human cells[J]. Cell, 2003, 114(2): 241-253.
[6] Meyerson M, Counter C M, Eaton E N, et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization[J]. Cell, 1997, 90(4): 785-795.
[7] Sharma G G, Gupta A, Wang H, et al. hTERT associates with human telomeres and enhances genomic stability and DNA repair[J]. Oncogene, 2003, 22(1): 131-146.
[8] Zhang R, Wang X, Guo L, et al. Growth inhibition of BEL404 human hepatoma cells by expression of mutant telomerase reverse transcriptase[J]. Int J Cancer, 2002, 97(2): 173-179.
[9] Theimer C A, Feigon J. Structure and function of telomerase RNA[J]. Curr Opin Struct Biol, 2006, 16(3): 307-318.
[10] Feng J, Funk W D, Wang S S, et al. The RNA component of human telomerase[J]. Science, 1995, 269(5228): 1236-1241.
[11] Marusic L, Anton M, Tidy A, et al. Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability[J]. Mol Cell Biol, 1997, 17(11): 6394-6401.
[12] Kim M M, Rivera M A, Botchkina I L, et al. A low threshold level of expression of mutant template telomerase RNA inhibits human tumor cell proliferation[J]. Proc Natl Acad Sci U S A, 2001, 98(14): 7982-7987.
[13] Li S, Rosenberg J E, Donjacour A A, et al. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutanttemplate telomerase RNA and antitelomerase shortinterfering RNA[J]. Cancer Res, 2004, 64(14): 4833-4840.
[14] Stohr B A, Blackburn E H. ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells[J]. Cancer Res, 2008, 68(13): 5309-5317.
[15] Gollahon L S, Holt S E. Alternative methods of extracting telomerase activity from human tumor samples[J]. Cancer Lett, 2000, 159(2): 141-149.
[16] 陈波, 梁江丽, 田晓平, 等. 水稻愈伤组织端粒酶催化特征检测[J]. 浙江理工大学学报, 2009, 26(4): 597-601.